Literature DB >> 12379733

Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli.

Richard A Hull1, William H Donovan, Michael Del Terzo, Colleen Stewart, Margaret Rogers, Rabih O Darouiche.   

Abstract

Recent clinical studies suggest that the deliberate colonization of the human bladder with a prototypic asymptomatic bacteriuria-associated bacterium, Escherichia coli 83972, may reduce the frequency of urinary tract infection in individuals with spinal cord injuries. However, the mechanism by which E. coli 83972 colonizes the bladder is unknown. We examined the role in bladder colonization of the E. coli 83972 genes papG and fimH, which respectively encode P and type 1 receptor-specific fimbrial adhesins. E. coli 83972 and isogenic papGDelta and papGDelta fimHDelta mutants of E. coli 83972 were compared for their capacities to colonize the neurogenic human bladder. Both strains were capable of stable colonization of the bladder. The results indicated that type 1 class-specific adherence and P class-specific adherence, while implicated as significant colonization factors in experiments that employed various animal model systems, were not required for colonization of the neurogenic bladder in human beings. The implications of these results with regard to the selection of potential vaccine antigens for the prevention of urinary tract infection are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379733      PMCID: PMC130346          DOI: 10.1128/IAI.70.11.6481-6484.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria.

Authors:  R A Hull; D C Rudy; W H Donovan; I E Wieser; C Stewart; R O Darouiche
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.

Authors:  R Hull; D Rudy; W Donovan; C Svanborg; I Wieser; C Stewart; R Darouiche
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Multifunctional nature of P fimbriae of uropathogenic Escherichia coli: mutations in fsoE and fsoF influence fimbrial binding to renal tubuli and immobilized fibronectin.

Authors:  B Westerlund; I van Die; C Kramer; P Kuusela; H Holthöfer; A M Tarkkanen; R Virkola; N Riegman; H Bergmans; W Hoekstra
Journal:  Mol Microbiol       Date:  1991-12       Impact factor: 3.501

4.  Pilot trial of bacterial interference for preventing urinary tract infection.

Authors:  R O Darouiche; W H Donovan; M Del Terzo; J I Thornby; D C Rudy; R A Hull
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

5.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

6.  Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.

Authors:  H L Mobley; K G Jarvis; J P Elwood; D I Whittle; C V Lockatell; R G Russell; D E Johnson; M S Donnenberg; J W Warren
Journal:  Mol Microbiol       Date:  1993-10       Impact factor: 3.501

7.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.

Authors:  M Aronson; O Medalia; L Schori; D Mirelman; N Sharon; I Ofek
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

8.  Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Authors:  L Hagberg; R Hull; S Hull; S Falkow; R Freter; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence.

Authors:  P Andersson; I Engberg; G Lidin-Janson; K Lincoln; R Hull; S Hull; C Svanborg
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.

Authors:  I Connell; W Agace; P Klemm; M Schembri; S Mărild; C Svanborg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  13 in total

1.  Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization.

Authors:  Barbara W Trautner; Richard A Hull; John I Thornby; Rabih O Darouiche
Journal:  Infect Control Hosp Epidemiol       Date:  2006-12-29       Impact factor: 3.254

2.  Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference.

Authors:  Deborah Horwitz; Tyler McCue; Abigail C Mapes; Nadim J Ajami; Joseph F Petrosino; Robert F Ramig; Barbara W Trautner
Journal:  J Infect       Date:  2015-06-03       Impact factor: 6.072

3.  Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.

Authors:  Rachel R Spurbeck; Ann E Stapleton; James R Johnson; Seth T Walk; Thomas M Hooton; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

Review 4.  Asymptomatic bacteriuria in elderly patients: significance and implications for treatment.

Authors:  Florian M E Wagenlehner; Kurt G Naber; Wolfgang Weidner
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.

Authors:  Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

6.  Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073.

Authors:  Nicola Holden; Makrina Totsika; Lynn Dixon; Kirsteen Catherwood; David L Gally
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

7.  Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters.

Authors:  K S Liao; S M Lehman; D J Tweardy; R M Donlan; B W Trautner
Journal:  J Appl Microbiol       Date:  2012-09-17       Impact factor: 3.772

Review 8.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

9.  Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference.

Authors:  Barbara W Trautner; Manuel E Cevallos; Huaiguang Li; Sarah Riosa; Richard A Hull; Sheila I Hull; David J Tweardy; Rabih O Darouiche
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

10.  A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization.

Authors:  A Prasad; M E Cevallos; S Riosa; R O Darouiche; B W Trautner
Journal:  Spinal Cord       Date:  2009-01-13       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.